BIOLOX
Device
Stryker Corporation
Total Payments
$377,993
Transactions
410
Doctors
207
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $6,580 | 16 | 10 |
| 2023 | $32,886 | 27 | 14 |
| 2022 | $83,311 | 65 | 38 |
| 2021 | $77,172 | 64 | 44 |
| 2020 | $53,805 | 37 | 26 |
| 2019 | $26,393 | 86 | 53 |
| 2018 | $89,095 | 68 | 43 |
| 2017 | $8,751 | 47 | 27 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $263,420 | 38 | 69.7% |
| Royalty or License | $60,000 | 1 | 15.9% |
| Consulting Fee | $30,725 | 8 | 8.1% |
| Food and Beverage | $16,504 | 344 | 4.4% |
| Travel and Lodging | $7,343 | 19 | 1.9% |
Payments by Type
Research
$263,420
38 transactions
General
$114,572
372 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 10 YEAR BIOLOX DELTA UNIVERSAL HEADS OUTCOMES STUDY | Stryker Corporation | $111,023 | 0 |
| INSIGNIA HIP STEM OUTCOMES STUDY | Stryker Corporation | $70,200 | 1 |
| A MINIMUM 5 YEAR, PROSPECTIVE, POST-MARKET, PILOT STUDY OF BIOLOX DELTA 36MM AND LARGER FEMORAL HEADS WITH TRIDENT X3 POLYETHYLENE INSERTS | Stryker Corporation | $40,841 | 0 |
| A RETROSPECTIVE CASE-CONTROLLED COMPARATIVE ANALYSIS OF OUTCOMES OF TWENTY CASES WITH DIRECT SUPERIOR APPROACH (AFTER LEARNING CURVE) VERSUS TWENTY CASES WITH MINI POSTERIOR APPROACH DURING TOTAL HIP ARTHROPLASTY | Stryker Corporation | $32,080 | 0 |
| RADIOGRAPHIC FIXATION OF THE 3D PRINTED TRIDENT II TRITANIUM ACETABULAR SYSTEM IN PRIMARY TOTAL HIP ARTHROPLASTY | Stryker Corporation | $3,376 | 0 |
| LFIT Anatomic Head with X3 - LFITAnatomic CoCr Femoral Heads With X3A Polyethylene Insert Study | Stryker Corporation | $1,920 | 0 |
| 10 Year Biolox Delta Universal Heads Outcomes Study | Stryker Corporation | $1,500 | 1 |
| LFIT Anatomic Head w X3 - LFIT Anatomic CoCr Femoral Heads With X3A Polyethylene Insert Study | Stryker Corporation | $1,360 | 0 |
| EARLY OUTCOMES WITH THE INSIGNIA FEMORAL STEM: A RADIOGRAPHIC, DEXA, AND CLINICAL ANALYSIS | Stryker Corporation | $1,020 | 0 |
| LFIT Anatomic Head w/ X3 - LFITAnatomic CoCr Femoral Heads With X3A Polyethylene Insert Study | Stryker Corporation | $100.00 | 0 |
Top Doctors Receiving Payments for BIOLOX — Page 9
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hand Surgery | Chula Vista, CA | $6.99 | 1 |
| , MD | Orthopaedic Surgery | Elmhurst, IL | $6.71 | 2 |
| Michael Simons | — | Fountain Valley, CA | $5.21 | 1 |
| , DPM | Foot & Ankle Surgery | Fountain Valley, CA | $5.21 | 1 |
| , DPM | Podiatrist | Fountain Valley, CA | $5.21 | 1 |
| , D.O | Orthopaedic Surgery | Clearwater, FL | $3.69 | 1 |
| , MD | Orthopaedic Surgery | Charlottesville, VA | $2.34 | 1 |
| , M.D | Orthopaedic Surgery | Oro Valley, AZ | $1.66 | 1 |
Ad
Manufacturing Companies
- Stryker Corporation $376,768
- DePuy Synthes Sales Inc. $1,225
Product Information
- Type Device
- Total Payments $377,993
- Total Doctors 207
- Transactions 410
About BIOLOX
BIOLOX is a device associated with $377,993 in payments to 207 healthcare providers, recorded across 410 transactions in the CMS Open Payments database. The primary manufacturer is Stryker Corporation.
Payment data is available from 2017 to 2024. In 2024, $6,580 was paid across 16 transactions to 10 doctors.
The most common payment nature for BIOLOX is "Unspecified" ($263,420, 69.7% of total).
BIOLOX is associated with 10 research studies, including "10 YEAR BIOLOX DELTA UNIVERSAL HEADS OUTCOMES STUDY" ($111,023).